The dose of hydroxyethyl starch 6% 130/0.4 for fluid therapy and the incidence of acute kidney injury after cardiac surgery: A retrospective matched study

PLoS ONE

Volumn 12, Issue 10, 2017, Pages

  Momeni, Mona ^a   Nkoy Ena, Lompoli ^a   Van Dyck, Michel ^a   Matta, Amine ^a   Kahn, David ^a   Thiry, Dominique ^a   Grégoire, André ^a   Watremez, Christine ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN; HETASTARCH; HETASTARCH DERIVATIVE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ELECTIVE SURGERY; EMERGENCY SURGERY; ERYTHROCYTE TRANSFUSION; FEMALE; FLUID THERAPY; HEART SURGERY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; RETROSPECTIVE STUDY; VOLUME; ACUTE KIDNEY INJURY; DOSE RESPONSE; HEART ASSIST DEVICE; HEART TRANSPLANTATION; MIDDLE AGED; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; REOPERATION; RISK FACTOR; THORAX SURGERY;

ACUTE KIDNEY INJURY; AGED; CARDIOPULMONARY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUID THERAPY; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RENAL REPLACEMENT THERAPY; REOPERATION; RISK FACTORS; THORACIC SURGICAL PROCEDURES;

EID: 85031767694     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0186403     Document Type: Article

References (24)

1. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Regaller M, Weiler N et al. German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008; 358: 125–139.
2. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D et al. CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012; 367: 1901–1911. https://doi.org/10.1056/NEJMoa1209759 PMID: 23075127
3. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A et al. 6S Trial Group; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med. 2012; 367: 124–134. https://doi.org/10.1056/NEJMoa1204242 PMID: 22738085
4. Vandijck DM, Reynvoet E, Blot SI, Vandecasteele E, Hoste EA. Severe infection, sepsis and acute kidney injury. Acta Clin Belg. 2007; 62: 332–336. PMID: 18283994
5. Zarjou A, Agarwal A. Sepsis and acute kidney injury. J Am Soc Nephrol. 2011; 22: 999–1006. https://doi.org/10.1681/ASN.2010050484 PMID: 21566052
6. Garwood S. Cardiac surgery-associated acute renal injury: new paradigms and innovative therapies. J Cardiothorac Vasc Anesth. 2010; 24: 990–1001. https://doi.org/10.1053/j.jvca.2010.05.010 PMID: 20702119
7. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006; 1: 19–32. https://doi.org/10.2215/CJN.00240605 PMID: 17699187
8. Kuitunen A, Vento A, Suojaranta-Ylinen R, Pettilä V. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg. 2006; 81: 542–546. https://doi.org/10.1016/j.athoracsur.2005.07.047 PMID: 16427848
9. Heringlake M, Knappe M, Vargas Hein O, Lufft H, Kindgen-Milles D, Böttiger BW et al. Renal dysfunction according to the ADQI-RIFLE system and clinical practice patterns after cardiac surgery in Germany. Minerva Anestesiol. 2006; 72: 645–654. PMID: 16865083
10. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004; 15: 1597–1605. PMID: 15153571
11. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998; 104: 343–348. PMID: 9576407
12. Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Cheng DC, Crowther M et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation. 2009; 119: 495–502. https://doi.org/10.1161/CIRCULATIONAHA.108.786913 PMID: 19153273
13. Lagny MG, Roediger L, Koch JN, Dubois F, Senard M, Donneau AF et al. Hydroxyethyl Starch 130/0.4 and the risk of acute kidney injury after cardiopulmonary bypass: A single-center retrospective study. J Cardiothorac Vasc Anesth. 2016; 30: 869–875. https://doi.org/10.1053/j.jvca.2015.10.010 PMID: 26774199
14. Bellomo R, Kellum JA, Ronco C. Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med. 2007; 33: 409–413. https://doi.org/10.1007/s00134-006-0478-x PMID: 17165018
15. Cruz DN, Bolgan I, Perazella MA, Bonello M, de Cal M, Corradi V et al. North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS—AKI): targeting the problem with the RIFLE criteria. Clin J Am Soc Nephrol. 2007; 2: 418–425. https://doi.org/10.2215/CJN.03361006PMID: 17699446
16. Magder S, Potter BJ, Varennes BD, Doucette S, Fergusson D; Canadian Critical Care Trials Group. Fluids after cardiac surgery: a pilot study of the use of colloids versus crystalloids. Crit Care Med. 2010; 38: 2117–2124. https://doi.org/10.1097/CCM.0b013e3181f3e08c PMID: 20802322
17. Jacob M, Fellahi JL, Chappell D, Kurz A. The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis. Crit Care. 2014; 18: 656. https://doi.org/10.1186/s13054-014-0656-0 PMID: 25475406
18. Bayer O, Schwarzkopf D, Doenst T, Cook D, Kabisch B, Schelenz C et al. Perioperative fluid therapy with tetrastarch and gelatin in cardiac surgery—a prospective sequential analysis. Crit Care Med. 2013; 41: 2532–2542. https://doi.org/10.1097/CCM.0b013e3182978fb6 PMID: 23978813
19. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidny injury. Crit Care. 2007; 11: R31. https://doi.org/10.1186/cc5713 PMID: 17331245
20. Mutter TC, Ruth CA, Dart AB. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev. 2013; 23: CD007594.
21. Dickenmann M, Oettl T, Mihatsch MJ. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis. 2008; 51: 491–503. https://doi.org/10.1053/j.ajkd.2007.10.044 PMID: 18295066
22. Raghunathan K, Shaw AD, Bagshaw SM. Fluids are drugs: type, dose and toxicity. Curr Opin Crit Care. 2013; 19: 290–298. https://doi.org/10.1097/MCC.0b013e3283632d77 PMID: 23817025
23. Jacob M, Chappell D. Reappraising Starling: the physiology of the microcirculation. Curr Opin Crit Care. 2013; 19: 282–289. https://doi.org/10.1097/MCC.0b013e3283632d5e PMID: 23743590
24. De Robertis E, Afshari A, Longrois D. The quest for the holy volume therapy. Eur J Anaesthesiol. 2016; 33: 483–487. https://doi.org/10.1097/EJA.0000000000000441 PMID: 27270704